Literature DB >> 24453768

Longitudinal changes in quality of life and related psychosocial variables in australians with multiple sclerosis.

Judy Ann Wollin1, Nancy Spencer1, Elizabeth McDonald1, Gary Fulcher1, Maureen Bourne1, Rex D Simmons1.   

Abstract

This study explored changes in quality of life (QOL) and psychosocial variables in a large cohort of people with multiple sclerosis (MS). A total of 1287 Australians with MS were administered self-report questionnaires at baseline and 24 months later to examine the impact of disease severity and duration, perceived stress, self-efficacy, depression, and social support on QOL and self-care. Over the 2-year survey period, MS remained stable for 70% of respondents. Disease severity correlated with social support at baseline but not at 24 months, when the only significant correlation with disease severity was that of the World Health Organization Quality of Life-100 instrument (WHOQOL-100) domain of Level of Independence. Although QOL improved across the WHOQOL-100 domains Physical, Psychological, Level of Independence, Social Relationships, and Environment, decreases were found in the WHOQOL-100 facet overall QOL and well-being as well as self-efficacy over the same time period. Hierarchical multiple regression was used to assess the utility of four control measures. MS disease severity and MS disease duration were entered at Step 1, explaining 16.1% of the variance in QOL. After entry of perceived stress, self-efficacy, social support, and the Depression, Anxiety and Stress Scale-21 (DASS-21) at Step 2, the total variance explained by the model as a whole was 55.8% (F6,1028 = 216.495, P < .001). Thus, even in the presence of stable disease and improvement in some WHOQOL-100 domains, overall QOL and self-efficacy had decreased at 2 years after the collection of baseline data. Loss of self-efficacy, increased stress, and depression are key factors in reduced QOL in people with MS.

Entities:  

Year:  2013        PMID: 24453768      PMCID: PMC3883011          DOI: 10.7224/1537-2073.2012-032

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  22 in total

1.  Treatment of depression for patients with multiple sclerosis in neurology clinics.

Authors:  D C Mohr; S L Hart; I Fonareva; E S Tasch
Journal:  Mult Scler       Date:  2006-04       Impact factor: 6.312

Review 2.  Natural history of multiple sclerosis: have available therapies impacted long-term prognosis?

Authors:  Maria Trojano; Damiano Paolicelli; Carla Tortorella; Piero Iaffaldano; Guglielmo Lucchese; Vita Di Renzo; Mariangela D'Onghia
Journal:  Neurol Clin       Date:  2011-05       Impact factor: 3.806

3.  Relationships among illness uncertainty, stress, coping, and emotional well-being at entry into a clinical drug trial.

Authors:  N M Wineman; K M Schwetz; D E Goodkin; R A Rudick
Journal:  Appl Nurs Res       Date:  1996-05       Impact factor: 2.257

4.  Learned self-help response to chronic illness experience: a test of three alternative learning theories.

Authors:  C J Braden
Journal:  Sch Inq Nurs Pract       Date:  1990

5.  Screening for depression among patients with multiple sclerosis: two questions may be enough.

Authors:  D C Mohr; S L Hart; L Julian; E S Tasch
Journal:  Mult Scler       Date:  2007-03       Impact factor: 6.312

Review 6.  Natural history of multiple sclerosis: early prognostic factors.

Authors:  Ellen M Mowry
Journal:  Neurol Clin       Date:  2011-05       Impact factor: 3.806

7.  The effect of telephone-administered cognitive-behavioral therapy on quality of life among patients with multiple sclerosis.

Authors:  David Cosio; Ling Jin; Juned Siddique; David C Mohr
Journal:  Ann Behav Med       Date:  2011-04

8.  Development and validation of a self-efficacy measure for people with multiple sclerosis: the Multiple Sclerosis Self-efficacy Scale.

Authors:  S A Rigby; C Domenech; E W Thornton; S Tedman; C A Young
Journal:  Mult Scler       Date:  2003-02       Impact factor: 6.312

9.  A comparative study of self-efficacy in men and women with multiple sclerosis.

Authors:  Cira Fraser; Sue Polito
Journal:  J Neurosci Nurs       Date:  2007-04       Impact factor: 1.230

10.  Depression and multiple sclerosis.

Authors:  A D Sadovnick; R A Remick; J Allen; E Swartz; I M Yee; K Eisen; R Farquhar; S A Hashimoto; J Hooge; L F Kastrukoff; W Morrison; J Nelson; J Oger; D W Paty
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

View more
  4 in total

1.  Selected health behaviors moderate the progression of functional limitations in persons with multiple sclerosis: Eleven years of annual follow-up.

Authors:  Alexa K Stuifbergen; Shelley Blozis; Heather Becker; Tracie Harrison; Vicki Kullberg
Journal:  Disabil Health J       Date:  2016-01-28       Impact factor: 2.554

2.  Self-efficacy as a longitudinal predictor of perceived cognitive impairment in individuals with multiple sclerosis.

Authors:  Abbey J Hughes; Meghan Beier; Narineh Hartoonian; Aaron P Turner; Dagmar Amtmann; Dawn M Ehde
Journal:  Arch Phys Med Rehabil       Date:  2015-01-15       Impact factor: 3.966

3.  Quality of life and psychological well-being in the early stages of multiple sclerosis (MS): Importance of adopting a biopsychosocial model.

Authors:  L B Strober
Journal:  Disabil Health J       Date:  2018-05-31       Impact factor: 2.554

4.  The Role of Stress Perception and Coping with Stress and the Quality of Life Among Multiple Sclerosis Patients.

Authors:  Aleksandra Kołtuniuk; Magdalena Kazimierska-Zając; Kinga Cisek; Justyna Chojdak-Łukasiewicz
Journal:  Psychol Res Behav Manag       Date:  2021-06-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.